Mount Yale Investment Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$713K Buy
2,673
+1,583
+145% +$429K 0.02% 603
2025
Q4
$273K Sell
1,090
-195
-15% -$51.8K 0.01% 613
2025
Q3
$369K Buy
1,285
+1,079
+524% +$289K 0.03% 474
2025
Q2
$54.1K Buy
+206
New +$50.2K ﹤0.01% 796
2018
Q4
Sell
-897
Closed -$132K 559
2018
Q3
$132K Sell
897
-213
-19% -$32.4K 0.02% 361
2018
Q2
$171K Sell
1,110
-5
-0.4% -$755 0.03% 320
2018
Q1
$155K Buy
+1,115
New +$164K 0.03% 329

Other funds holding LH

Mount Yale Investment Advisors's LH Position: Q1 2026 in Review

Mount Yale Investment Advisors increased its Labcorp (LH) stake by 145% in Q1 2026, buying an estimated $429K and bringing the position to 2,673 shares worth $713K. The position accounts for 0.02% of the portfolio, ranked #603.

Mount Yale Investment Advisors first reported a position in LH in Q1 2018 and has held it in 7 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Mount Yale Investment Advisors held 2,673 shares of Labcorp worth $713K as of Q1 2026.
  • Mount Yale Investment Advisors bought 1,583 Labcorp shares in Q1 2026, an estimated $429K.
  • Labcorp made up 0.02% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #603 holding.
  • Mount Yale Investment Advisors first reported a position in Labcorp in Q1 2018 and has held it in 7 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.